Open Label Immunotherapy Trial of Inoperable Pancreatic Cancer
NCT03165591
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Pancreatic Cancer Non-resectable
Interventions
BIOLOGICAL:
V3-P
Sponsor
Immunitor LLC